Shire Human Genetic Therapies, Inc.

Insider profile

Shire Human Genetic Therapies, Inc.'s trades of Translate Bio Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
330.32
Quantity 63,500 -3.8%
Value US$1,796,663
Transaction date
Sale
Price
174.13
Quantity 81,848 +13.8%
Value US$1,493,923
Transaction date
Sale
Price
313.46
Quantity 13,593 -46.0%
Value US$314,212
Transaction date
Sale
Price
20.53
Quantity 1,400 -0.0%
Value US$28,742
Transaction date
Sale
Price
19.85
Quantity 107,072 -1.5%
Value US$2,125,379
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2020-06-05 2020-06-03 S Sale
63,500 -3.8%
330.32
US$1,796,663
63,500 -3.8% 330.32 US$1,796,663
2020-06-03 2020-06-02 S Sale
81,848 +13.8%
174.13
US$1,493,923
81,848 +13.8% 174.13 US$1,493,923
2020-06-03 2020-06-02 S Sale
13,593 -46.0%
313.46
US$314,212
13,593 -46.0% 313.46 US$314,212
2020-06-03 2020-06-01 S Sale
1,400 -0.0%
20.53
US$28,742
1,400 -0.0% 20.53 US$28,742
2020-06-03 2020-06-01 S Sale
107,072 -1.5%
19.85
US$2,125,379
107,072 -1.5% 19.85 US$2,125,379